Industry: Pharmaceuticals, Biotechnology
Founded in 2000, Chemogen is a privately held company focused on developing novel proprietary tests for the diagnosis of infectious diseases, initially tuberculosis. Chemogen’s scientific team, led by Dr. Vladimir Koulchin, has developed a revolutionary urine-based TB diagnostic test, capable of accelerating TB detection and playing an important role in eradicating tuberculosis while opening significant market opportunities worldwide. Chemogen’s technology is adaptable to multiple existing diagnostic formats. Chemogen’s test demonstrates better performance than the current standard of sputum microscopy in those co-infected with TB and ( www.chemogen.com )
Chemogen Inc
125 John Roberts Road Suite 5
South Portland, Maine 04106
USA
Tel: (207) 772-2931